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A NUMBER of different and apparently unrelated treatments, not themselves
carcinogenic, have been shown to increase the incidence of epidermal tumours in
skin painted with chemical carcinogens. This action, which has been called
co-carcinogenic, has been studied by many investigators. Reports up to 1944
have been reviewed by Berenblum (1944). Later work has been mainly con-
cerned with the properties ofcrotonoil, themost powerful knownco-carcinogen for
mouse skin (e.g., Berenblum and Shubik, 1947a, 1947b, 1949a, 1949b; Salaman
and Gwynn, 1951; Salaman, 1952). Shubik (1950) tested several other sub-
stances, but found none with detectable action. In the present work chemical
agents belonging to several classes have been tested for co-carcinogenic power
by a technique previously used (Salaman and Gwynn, 1951) and briefly described
below.
Group 1: Substances which react with SH groups.
Many skin irritants, lachrymators, and vesicants belong to this class (Dixon
and Needham, 1946). The following were selected for trial:
Jodoacetic acid.
Jodoacetamide (prepared by Dr. D. H. Adams ofthis Department).
Chloroacetophenone (kindly supplied by Dr. M. Dixon of the Department
of Biochemistry, Cambridge).
Preliminary tests showed that these all produced epidermal hyperplasia
when applied to mouse skin as solutions in acetone.
Acetic acid was included in this group, though not irritant in comparable
concentration, to control the possible effect of the acid reaction of iodoacetic
acid.
Berenblum (1935) found that iodoacetic acid, though strongly irritant, was
not carcinogenic when applied alone to mouse skin, nor did it modify tumour
production when applied alternately with tar. Visser and Ten Seldam (1938)
reported similar results with chloroacetophenone.
Group 2: Quinones.
1: 4 Naphthoquinone was shown to be a weak carcinogen when applied in
benzene solution to the skin of mice, and benzoquinone had a similar action
(Takizawa, 1940). Klein and Rusch (1944) showed that repeated applicationSUBSTANCES TESTED FOR CO-CARCINOGENIC ACTION
of the former compound to the skin of mice increased tumour incidence following
twice-weekly applications of 0*3 per cent methylcholanthrene in benzene for
16 weeks.
These and a number of other quinones, and their substituted derivatives,
were first tested for hyperplastic action on mouse epidermis (Table I). Four
selected members of the group, two hyperplastic and two non-hyperplastic,
were then tested for co-carcinogenic action.
TABLE I.
Epidermal
Substance. hyperplasia.
M/30 5 Hydroxy-1:4 naphthoquinone. . . . . Strong.
M/30 2 Hydroxv-1:4 naphthoquinone. . . . None.
m/3OAceto-menaphthone . . . . . . Very slight.
M/30 2-Methyl 1:4 naphthoquinone-4-carboxymethoxime
M/30 4 Amino 1-naphthol. . . . . None.
Saturated solution (ca. M/200) anthroquinone .
Saturated solution ( ,, ) phenanthroquinone
Saturated solution ( ,, ) benzanthrone . . . Very slight.
M/30 1:4 Naphthoquinone . . . . . . Strong.
M/30 1:2 Naphthoquinone . . . . . . None.
M/30 Benzoquinone . . . . . ..
M/30 Hydroquinone. . . . . .
M/30 2 Methyl-1:4 naphthoquinone . . . . . Strong.
Acetone (A.R.) was the solvent throughout.
Group 3: Hormones.
Testosterone has been shown to delay carcinogenesis by chemical carcinogens
applied to the skin or injected subcutaneously. (Flaks and Ber, 1938a, 1938b,
1939; Flaks, 1948). Oestrone has been shown to increase the mitotic rate in
epidermis (Bullough, 1950). Oestradiol was tested for co-carcinogenic action.
Group 4: Miscellaneous-group of irritants, vesicants, and purgatives.
The following were also tested as co-carcinogens:
Turpentine, an irritant for mouse skin (Berenblum, 1935, Glicksmann, 1945)
was shown to be co-carcinogenic for rabbit skin (Rous and Kidd, 1941), but not
for mouse skin (Shubik, 1950).
Cantharidin, though strongly irritant for mouse skin, reduced the yield of
tumours when applied alternately with tar (Berenblum, 1935).
Mustard oil, an irritant and vesicant for human skin, was found by Visser
and Ten Seldam (1938) to be non-carcinogenic, and without effect on tar carcino-
genesis, in mouse skin.
Scarlet R was selected from a number of substances which have been shown
to produce epithelial hyperplasia when injected subcutaneously (for review see
Borst, 1924).
Oleic acid was shown by Shubik (1950) to cause slight hyperplasia of mouse
skin, but to have no co-carcinogenic action when applied after a single dose of a
carcinogen. Twort and Twort (1939), however, showed that it augmented
carcinogenic action of a small dose of 3: 4 benzpyrene.
Podophyllin resin was selected from a number of strong purgatives because it
was found to have a hyperplastic action on mouse skin. It also produces mitotic
483484 R. H. GWYNN AND M. H. SALAMAN
abnormalities (King and Cauldwell, 1949) Berenblum (1951) found it non-
carcinogenic when applied alone to mouse skin, and slightly anti-carcinogenic
when applied alternately with benzpyrene.
Other purgatives (jalap, colocynth, aloes, scammony, and guiacum) had no
appreciable hyperplastic effect on mouse epidermis, and were not further tested.
METHODS.
Mice.-Stock albinos ofthe " S " strain (Salaman and Gwynn, 1951) were used.
They were fed on rat cubes made according to the Rowett Institute formula
(Thomson, 1930), and water ad libitum.
Primary treatment.-An initial application of 0 3 ml. of 0-1 or 0-15 per cent
9: 10 dimethyl-I 2 benzanthracene (DMBA) in acetone was made to the whole
back, after the hair had been clipped
Interval.-Before further treatment a period varying between 21 and 39 days
was allowed to elapse. The exact length of this interval, in view of Berenblum's
results with croton oil (Berenblum and Shubik, 1949b), was not considered to be
critical.
Secondary treatment.-Substances to be tested for co-carcinogenic action were
dissolved in acetone in concentrations found, in preliminary tests, to be the maxi-
mum tolerated without severe crusting or ulceration. Weekly, or occasionally
twice a week, 0.3 ml. amounts of these solutions were applied to the previously
treated areas.
In a few cases the concentration and frequency of these applications had to be
varied during the course ofthe experiment, owing to the development ofexcessive
crusting, as recorded below. Acetone (AR grade) was the solvent throughout,
but in the case of Scarlet R, 10 per cent liquid paraffin, and in that of oestradiol,
10 per cent arachis oil, was added. These treatments were continued for periods
varying from 140 to 200 days. They are recorded in Table II.
TABLE II.-Incidence of Skin Tumours in Treated Mlice.
Group.
1 .
2 .
3 .
No. o1
mice.
12
16
12
Primary
treatment Inter-
f (DMBA val in
%o). days.
. 0-15 . - .
. 0-1 . - .
. 0o15 . 21 .
4 . 13 0-15 21
5 . 16 . 0-1 39
6 . 12 . 0 15 21
7 . 12 . 0 15 21
8 . 16 . 0 1 . 39
9 . 16 0-1 39
10 12 . 0-15 21
11 . 12 . 0-15 . 21
12 . 12 . 0-15 . 21
13 . 16 . 0-1 . 39
14 . 16 . 0- 1 . 39
15 . 16 . 0 1 . 39
16 . 16 0-1 39
17 . 19 . 0-15 . 21
18 . 19 . 0-15 . 21
19 . 18 . 0-15 . 21 2
20 . 19 . 0 15 . 21
Secondary treatment.
A
Substance. Duration.
None
Acetone Twice weekly,
12 weeks,
weekly,
15 weeks
Croton oil 0. 5 0 As group 3
0-5//O Weekly, 20
weeks
lodoacetic acid M/20-M/10 As Group 3
Chloroacetophenone M/40-M/20 As Group 3
Iodoacetamide M/33}-M/15 As Group 5
Acetic acid M/10-M/5 As Grouip 5
Oestradiol 0 05%/ As Groutp 3
Scarlet R, satutrated solution As Group 3
Oleic acid, undiluted As Group 3
Turpentine 50% As Group 5
Cantharadin 0 01-0 0 05% As Group 5
Podophyllin 01-0 33% As Group 5
Mustard oil 3-0-4-5% As Grouip 5
1:4-naphthoquinone MI/30 Weekly, 27
weeks
1:2-naphthoquinoile M/30 As Group 17
methyl-1:4-naphthoquinone M/33 As Group 17
Benzoqinone M/30 As Group 17
Hyper-
plasia
ofepi-
dermis.
0
0
0
+
++
+ +
+ +
++
0
0
+
+
++
+
++
+
++
0
0
Tumour
bearing
mice/sur- No. of
vivors. tumours.
2/9 . 2
1/12 . 1
5/5
12/16
8/10
9/12
4/16
1/16
0/6
2/10
2/10
2/15
0/5
1/14
1/16
3/18
1/18
6/17
0/13
26
189
54
20
4
1
0
3
2
2
0
1
2
3
1
6
0SUBSTANCES TESTED FOR CO-CARCINOGENIC ACTION
Biopsies.-Pieces of skin, approximately 1 X 0 5 cm. in area, were removed
under ether anaesthesia from the treated areas at intervals during the secondary
treatments. Tissues were fixed in Zenkers fluid, and stained with haematoxylin
and Eosin-Biebrich Scarlet [Eosin (water soluble) and Biebrich Scarlet each
0'5 g., glycerol 10 ml., methanol 40 ml., distilled water 450 ml.]
Tumour incidence.-Tumours were recorded weekly, and a final count made
3 days after the last treatment. They were observed visually for signs of malig-
nancy, and sections were cut, after autopsy, in suspicious cases.
RESULTS.
In general, 5-10 days after the primary painting with the carcinogen most
mice showed some degree of epilation. About a third developed a mild degree of
scabbing, or firm raised ridges or lumps ofthickened skin, ususally in the scapular
region, 10 to 15 X 2 to 3 mm. in area; most of these were visible for only 2 to
3 weeks, though a few gave rise to tumours later. By the time secondary treat-
ment was started the hair had grown, and there were only a small number of
persistent thickenings and scars visible. Very little further epilation or crusting
occurred during the secondary treatments, except in the cases of iodoacetic acid,
chloroacetophenone, cantharidin, and podophyllin.
Tumour incidence.
All tumours appeared to be benign papillomas macroscopically, of diameters
1 to 10 mm. No evidence ofmalignancy was found in the few suspicious tumours
examined microscopically. Subsequent observation in this laboratory has shown
(unpublished results) that a much longer time must elapse before an appreciable
number of malignant tumours are seen after a small dose of a carcinogen followed
by repeated treatment with a co-carcinogen.
A few tumours appeared in the control groups (1 and 2, no secondary treat-
ment): 4 among 21 survivng mice; and only one tumour among 12 surviving
mice in Group 3 (acetone as secondary treatment).
In Groups 4 and 5 (croton oil as secondary treatment) there were 215 tumours
on 17 surviving mice: many more were seen at an earlier date, but a number of
mice bearing large numbers of tumours died before the end of the experiment.
Among the remaining groups, only in 6 and 7 (iodoacetic acid and chloroaceto-
phenone as secondary treatments, respectively), was the tumour incidence signi-
ficantly greater than that in the control group. The 10 surviving mice of Group
6 carried between them 54 tumours, while the 12 survivors of Group 7 carried 10
tumours between them, at the end of the experiment.
In Group 17 (1: 4 naphthoquinone), 19 (2 methyl 1: 4 naphthoquinone), 8
(iodoacetamide) and 11 (Scarlet R), the tumour incidence was slightly higher than
that of the controls, but these results are not statistically significant.
Details ofthese results are found in Table II, and the course oftumour appear-
ance for Groups 1, 4, 6, 7, and 19, expressed as the mean number of tumours per
surviving mouse plotted against time, in Fig. 1.
By comparing these means at 15 and 22 weeks after the start of secondary
treatments it was shown that tumour incidences in Groups 4, 6, and 7 are signi-
ficantly higher than in Group 1 (controls,) and also different from each other,
whereas the incidence in Group 19 is not significantly different from that of the
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FIGuRE 1.
* Group 1 (no secondary treatment).
+ Group 4 (secondary treatment: croton oil).
O Group 6 ( ,, ,, : iodoacetic acid). A Group 7 ( ,, ,, : chloroacetophenone). x Group 19 ( ,, ,, : 2-methyl 1:4-naphthoquinone).
All groups received one primary treatment with 9:10 dimethyl 1:2 benzanthracene 3 to 6 weeks
before the beginning ofsecondary treatments.
controls, though the figures suggest that such a difference might have been
observed in a larger experiment.
Histology.
All those substances which were definitely co-carcinogenic caused marked
epidermal hyperplasia, but hyperplasia was also caused by substances that were
not co-carcinogenic. A measure of the hyperplasia was obtained by counting the
total number of cells per 1 mm. length ofepidermis, excluding hair follicles.
In addition thepercentage of " resting cells", i.e. basal cellsproper (Glucksman
1945), in the epidermis of mice in 8 of the groups was determined by methodsSUBSTANCES TESTED FOR CO-CARCINOGENIC ACTION
previously described (Salaman and Gwynn, 1951). A single count was made on
the epidermis of mice taken from the selected groups, at about the time that
tumours were beginning to appear in the croton oil-treated animals (59-66 days
after the start of secondary treatment). Of the groups selected three had been
treated with substances that produced both epidermal hyperplasia and tumours
(croton oil, iodoacetic acid, and chloroacetophenone), and four with substances
that caused epidermal hyperplasia but no tumours (iodoacetamide, oleic acid,
Scarlet R, and mustard oil). The last substance caused only a weak hyperplasia.
The percentage ofresting cellswas significantly raised above that ofthe control
group (1) in the chloroacetophenone and iodoacetic acid groups (6 and 7); as well
as in the croton oil group (4) (as previously reported, Salaman and Gwynn, 1951),
but not in any of the other groups.
The total number of cells per mm. of epidermis was significantly higher than
in the control in all the selected groups, except that treated with mustard oil,
and highest in the croton oil group. Total and resting cell counts are given in
Table III.
DISCUSSION.
Ofthe substances tested, iodoacetic acid andchloroacetophenone werefoundto
possess marked co-carcinogenic power, though in the concentrations used this was
inferior to that of croton oil. 2-Methyl-1: 4 naphthoquinone slightly increased
tumour incidence compared with controls; this result is suggestive but, under
the conditions ofthis experiment, it cannot be shown to be statistically significant.
The effects produced by iodoacetamide, 1: 4 naphthoquinone, and Scarlet R were
even less definite. The other substances were inactive.
TABLE III.-Differential Cell Counts in Treated Skin.
Resting cells
Days after as % of all Totalcells per
Secondary secondary epidermal mm. length of
Group. treatment. treatment. cells. epidermis.
1 . None . 66 . 16 5±0 8 . 193± 5-5
4 . Croton oil . 66 . 34-2±0-8 . 355±23-9
6 . Iodoacetic acid . 66 . 23-6±0-7 . 258+12.6
7 . Chloroacetophenone . 66 . 22 5+0 6 . 282±11-3
8 . lodoacetamide . 59 . 16.0±0.8 . 246±19-2
11 . Scarlet R . 66 . 16-2±0-8 . 250±16-7
12 . Oleic acid . 66 . 17-6±0-8 . 255+ 8.4
16 . Mustard oil . 59 . 15-8±08 . 202± 5-8
All groups received one primary treatment with 9:10 dimethyl 1:2 benzanthracene 3 to 6 weeks
before the beginning ofsecondary treatments.
From Table III it is evident that iodoacetic acid, chloroacetophenone, and
croton oil (the co-carcinogenic substances) increase the percentage of resting cells
in mouse epidermis previously treated with a carcinogen, while the non-co-carcino-
genic substances tested do not. This suggests a connection between the two
properties. The significance of such a connection is at present quite unknown.
Epidermal hyperplasia, however, measured as the increase in total number of
cells per mm. length ofepidermis, is not significantly greater in the co-carcinogenic
than in the non-co-carcinogenic groups. Hyperplasia may be a necessary, but
is not a sufficient, condition for co-carcinogenic action.
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It is evident too, that the purgative or vesicant properties ofthe agents tested
are not associated with co-carcinogenicity.
The occurence of two co-carcinogenic substances among the three -SH
reactors tested is interesting. It has been suggested that carcinogens themselves
may react with -SH groups (Crabtree, 1945, 1947; Calcutt, 1949). Crabtree
(1940) found that a number of -SH reactors retarded tumour formation when
applied alternatively with a carcinogenic hydrocarbon to mouse skin, but that
one of them, chloracetone (Crabtree, 1941) slightly stimulated tumour formation
when applied after a course of treatment with benzpyrene. The failure of iodo-
acetamide to produce tumours may have been due to faulty penetration or rapid
removal. It is clear that so little is known ofthe effective concentration at suscep-
tible sites in a tissue ofapplied substances ofvarying physical properties that it is
not profitable to attempt to correlate observed co-carcinogenic potency with
other chemical activity.
SUMMARY.
1. A number ofsubstances were tested for co-carcinogenic activity ofthe type
shown by croton oil, namely the production of tumours when applied repeatedly
to mouse skin after a single application of a carcinogenic hydrocarbon. They
included substances which react with -SH groups, various quinones, oestradiol,
and a group of miscellaneous skin irritants and purgatives.
2. Of these only two, iodoacetic acid and chloroacetophenone, both -SH
reactors, gave rise to a significant tumour incidence.
3. Both these co-carcinogenic substances produced epidermal hyperplasia,
but several of the non-co-carcinogenic substances had a similar effect.
4. Both iodoacetic acid and chloroacetophenone, when applied after the
carcinogen as desdribed, increased significantly the proportion of " resting cells "
(Glucksmann, 1945) in the epidermis, as croton oil had been shown to do (Salaman
and Gwynn, 1951). None of the other substances tested had this property.
We are indebted to D. I. Connell, W. J. Milton and J. Rawlings for skilled
technical assistance.
The expenses of this research were partly defrayed out of a block grant from
the British Empire Cancer Campaign.
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